Anju Pal

Unveiling the antidiabetic activity and potential molecular mechanisms of a polyherbal HP-β-cyclodextrin inclusion complex to reveal the integrated network pharmacology, docking studies against the PP242–mTOR complex and In-Vivo investigations

Type 2 diabetes mellitus (T2DM) is a rapidly increasing global health concern characterized by hyperglycemia, insulin resistance, and increased oxidative stress. Despite the availability of several antidiabetic therapies, long-term management remains challenging due to adverse ef...